After pharma CEO pushes Trump, FDA drops request for more data on his drug
DocuTicker DocuBase Category: GAO 2017-07-12
Summary:
The pharmaceutical industry is abuzz with hopes for easier FDA reviews.
Link:
https://arstechnica.com/?p=1131849From feeds:
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific MethodCyberlaw » Ars Technica
Music and Digital Media » Ars Technica